Table 3

Reclassification analysis, for the endpoint of in-hospital mortality, using continuous reclassification showing the net reclassification index (NRI) of adding N-terminal pro B-type natriuretic peptide (NT-proBNP) or trimethylamine N-oxide (TMAO) to the classification using ADHERE (left), OPTIMIZE-HF (centre) and GWTG-HF (right) scoring only, and for adding TMAO to the classification using the clinical risk algorithm scoring with NT-proBNP

In-hospital mortality
Adding NT-proBNP to ADHEREAdding NT-proBNP to OPTIMIZE-HFAdding NT-proBNP to GWTG
EndpointNRI (95% CI)p ValueEndpointNRI (95% CI)p ValueEndpointNRI (95% CI)p Value
No−4.2 (−10.8 to 2.3)NSNo−10.9 (−17.8 to −4.1)0.002No−7.8 (−14.7 to 1.0)0.025
Yes19.4 (−3.7 to 42.5)NSYes35.3 (11.5 to 59.1)0.004Yes11.8 (−12.0 to 35.5)NS
Total15.2 (−8.8 to 39.2)NSTotal24.4 (−0.4 to 49.1)NSTotal3.9 (−20.8 to 28.7)NS
Adding TMAO to ADHEREAdding TMAO to OPTIMIZE-HFAdding TMAO to GWTG
EndpointNRI (95% CI)p ValueEndpointNRI (95% CI)p ValueEndpointNRI (95% CI)p Value
No17.8 (11.2 to 24.3)<0.0005No23.3 (16.5 to 30.2)<0.0005No20.5 (13.7 to 27.3)<0.0005
Yes8.3 (−14.8 to 31.4)NSYes13.0 (−10.6 to 36.6)NSYes7.2 (−16.3 to 30.8)NS
Total26.1 (2.1 to 50.1)0.033Total36.4 (11.8 to 60.9)0.004Total27.8 (3.2 to 52.3)0.027
Adding TMAO to ADHERE and NT-proBNPAdding TMAO to OPTIMIZE-HF and NT-proBNPAdding TMAO to GWTG and NT-proBNP
EndpointNRI (95% CI)p ValueEndpointNRI (95% CI)p ValueEndpointNRI (95% CI)p Value
No15.6 (9.0 to 22.1)<0.0005No17.1 (10.2 to 23.9)<0.0005No17.2 (10.3 to 24.0)<0.0005
Yes11.1 (−12.0 to 34.2)NSYes14.7 (−9.1 to 38.5)NSYes11.8 (−12.0 to 35.5)NS
Total26.7 (2.7 to 50.7)0.029Total31.8 (7.0 to 56.5)0.012Total28.9 (4.2 to 53.7)0.022